Prostate Cancer study: NLP+AI Report
Official title RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
ClinicalTrials.gov ID: NCT06856694
What this study is testing
- What it's testing
- This study checks if using AI to review doctor-patient conversations improves how risks are explained and helps patients choose the right treatment.
- Who it's for
- Men recently diagnosed with early-stage prostate cancer who are meeting with a doctor to discuss treatment options.
- What's involved
- Participants will have their treatment consultation recorded. Some doctors will receive AI feedback on how they explained risks, while others will not. Everyone will have a follow-up call and fill out a short survey.
- Time commitment
- The study involves one main consultation, a follow-up phone or video call, and a brief survey.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Physician (1) Physicians who typically counsel prostate cancer patients (Urology, Radiation Oncology, Medical Oncology) Patient 1.
- Patients with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy;
- Ability to read and write in English. Patient
You likely can't join if
- Under 18 years of age;
- people with difficulty communicating or dementia;
- Non-English speakers, given that our NLP-based tools cannot be used with languages other than English;
- Patients with locally advanced or metastatic prostate cancer;
- Patients who have already been treated for clinically localized prostate cancer.
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.